To examine the role of extracellular HMGB1 in the development of pressure overload‐induced cardiac hypertrophy and heart failure, exogenous HMGB1 and HMGB1 box A were used to treat mice with TAC. Here, HMGB1 is linked to cardiac hypertrophy.